These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 24887158)
1. Non-invasive assessment of retinal alterations in mouse models of infantile and juvenile neuronal ceroid lipofuscinosis by spectral domain optical coherence tomography. Groh J; Stadler D; Buttmann M; Martini R Acta Neuropathol Commun; 2014 May; 2():54. PubMed ID: 24887158 [TBL] [Abstract][Full Text] [Related]
2. Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome. Appu AP; Bagh MB; Sadhukhan T; Mondal A; Casey S; Mukherjee AB J Inherit Metab Dis; 2019 Sep; 42(5):944-954. PubMed ID: 31025705 [TBL] [Abstract][Full Text] [Related]
3. Immunomodulation with minocycline rescues retinal degeneration in juvenile neuronal ceroid lipofuscinosis mice highly susceptible to light damage. Dannhausen K; Möhle C; Langmann T Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30042155 [TBL] [Abstract][Full Text] [Related]
4. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease). Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019 [TBL] [Abstract][Full Text] [Related]
5. Sialoadhesin promotes neuroinflammation-related disease progression in two mouse models of CLN disease. Groh J; Ribechini E; Stadler D; Schilling T; Lutz MB; Martini R Glia; 2016 May; 64(5):792-809. PubMed ID: 26775238 [TBL] [Abstract][Full Text] [Related]
6. Phenotypic characterization of a mouse model of juvenile neuronal ceroid lipofuscinosis. Katz ML; Johnson GS; Tullis GE; Lei B Neurobiol Dis; 2008 Feb; 29(2):242-53. PubMed ID: 17962032 [TBL] [Abstract][Full Text] [Related]
7. Optic nerve degeneration in a murine model of juvenile ceroid lipofuscinosis. Sappington RM; Pearce DA; Calkins DJ Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3725-31. PubMed ID: 12939285 [TBL] [Abstract][Full Text] [Related]
8. Ocular morphology and function in juvenile neuronal ceroid lipofuscinosis (CLN3) in the first decade of life. Preising MN; Abura M; Jäger M; Wassill KH; Lorenz B Ophthalmic Genet; 2017; 38(3):252-259. PubMed ID: 27486012 [TBL] [Abstract][Full Text] [Related]
9. Compromised astrocyte function and survival negatively impact neurons in infantile neuronal ceroid lipofuscinosis. Lange J; Haslett LJ; Lloyd-Evans E; Pocock JM; Sands MS; Williams BP; Cooper JD Acta Neuropathol Commun; 2018 Aug; 6(1):74. PubMed ID: 30089511 [TBL] [Abstract][Full Text] [Related]
10. Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium. Zhong Y; Mohan K; Liu J; Al-Attar A; Lin P; Flight RM; Sun Q; Warmoes MO; Deshpande RR; Liu H; Jung KS; Mitov MI; Lin N; Butterfield DA; Lu S; Liu J; Moseley HNB; Fan TWM; Kleinman ME; Wang QJ Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165883. PubMed ID: 32592935 [TBL] [Abstract][Full Text] [Related]
11. Behavioral assessment in mouse models of neuronal ceroid lipofuscinosis using a light-cued T-maze. Wendt KD; Lei B; Schachtman TR; Tullis GE; Ibe ME; Katz ML Behav Brain Res; 2005 Jun; 161(2):175-82. PubMed ID: 15885820 [TBL] [Abstract][Full Text] [Related]
12. Fingolimod and Teriflunomide Attenuate Neurodegeneration in Mouse Models of Neuronal Ceroid Lipofuscinosis. Groh J; Berve K; Martini R Mol Ther; 2017 Aug; 25(8):1889-1899. PubMed ID: 28506594 [TBL] [Abstract][Full Text] [Related]
13. Cln1-mutations suppress Rab7-RILP interaction and impair autophagy contributing to neuropathology in a mouse model of infantile neuronal ceroid lipofuscinosis. Sarkar C; Sadhukhan T; Bagh MB; Appu AP; Chandra G; Mondal A; Saha A; Mukherjee AB J Inherit Metab Dis; 2020 Sep; 43(5):1082-1101. PubMed ID: 32279353 [TBL] [Abstract][Full Text] [Related]
14. A murine model of infantile neuronal ceroid lipofuscinosis-ultrastructural evaluation of storage in the central nervous system and viscera. Galvin N; Vogler C; Levy B; Kovacs A; Griffey M; Sands MS Pediatr Dev Pathol; 2008; 11(3):185-92. PubMed ID: 17990914 [TBL] [Abstract][Full Text] [Related]
15. Ocular phenotype in a mouse gene knockout model for infantile neuronal ceroid lipofuscinosis. Lei B; Tullis GE; Kirk MD; Zhang K; Katz ML J Neurosci Res; 2006 Oct; 84(5):1139-49. PubMed ID: 16881055 [TBL] [Abstract][Full Text] [Related]
16. Immune cells perturb axons and impair neuronal survival in a mouse model of infantile neuronal ceroid lipofuscinosis. Groh J; Kühl TG; Ip CW; Nelvagal HR; Sri S; Duckett S; Mirza M; Langmann T; Cooper JD; Martini R Brain; 2013 Apr; 136(Pt 4):1083-101. PubMed ID: 23485853 [TBL] [Abstract][Full Text] [Related]
17. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect. de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383 [TBL] [Abstract][Full Text] [Related]
19. Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. Gupta P; Soyombo AA; Atashband A; Wisniewski KE; Shelton JM; Richardson JA; Hammer RE; Hofmann SL Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13566-71. PubMed ID: 11717424 [TBL] [Abstract][Full Text] [Related]
20. Intrathecal enzyme replacement therapy improves motor function and survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis. Lu JY; Nelvagal HR; Wang L; Birnbaum SG; Cooper JD; Hofmann SL Mol Genet Metab; 2015; 116(1-2):98-105. PubMed ID: 25982063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]